Kestra Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,477	Closed	-$101K	–	4274
2025 Q4	$101K	Buy	+6,477	New	+$92.6K	﹤0.01%	3414
2024 Q2	–	Sell	-11,918	Closed	-$166K	–	2684
2024 Q1	$166K	Sell	11,918 -599	-5%	-$8.71K	﹤0.01%	2315
2023 Q4	$179K	Buy	12,517 +353	+3%	+$5.01K	﹤0.01%	2130
2023 Q3	$188K	Sell	12,164 -259	-2%	-$4.01K	﹤0.01%	1932
2023 Q2	$195K	Sell	12,423 -6,781	-35%	-$111K	﹤0.01%	1911
2023 Q1	$316K	Sell	19,204 -17,492	-48%	-$279K	﹤0.01%	1530
2022 Q4	$572K	Buy	36,696 +10,041	+38%	+$140K	0.01%	1326
2022 Q3	$346K	Buy	26,655 +761	+3%	+$10.6K	﹤0.01%	1525
2022 Q2	$364K	Buy	25,894 +3,925	+18%	+$56K	﹤0.01%	1506
2022 Q1	$315K	Sell	21,969 -6,619	-23%	-$97.2K	﹤0.01%	1568
2021 Q4	$390K	Sell	28,588 -7,940	-22%	-$111K	﹤0.01%	1450
2021 Q3	$598K	Sell	36,528 -330	-0.9%	-$5.54K	0.01%	1292
2021 Q2	$620K	Sell	36,858 -926	-2%	-$15.8K	0.01%	1171
2021 Q1	$690K	Buy	37,784 +25,054	+197%	+$451K	0.01%	1038
2020 Q4	$231K	Buy	+12,730	New	+$223K	﹤0.01%	1627